Higher plasma concentrations of the N-terminal fragment of brain natriuretic peptide (NT-pro-BNP) and the tumor necrosis factor-alpha (TNF-alpha) have been observed in patients affected by chronic heart failure (CHF). Recent clinical studies have tried to correlate the plasma levels of these biomarkers with severity of the disease. To evaluate the role of NT-pro-BNP, TNF-alpha and C-reactive protein (CRP) in a population of geriatric patients affected by CHF, and to assess their different plasma levels in diabetics and in normoglycemic patients, we enrolled 57 patients affected by CHF: 29 patients were diabetic and 28 were normoglycemic. Clinical and echocardiographic examinations were performed in all patients, in order to evaluate the NYHA-class and the left ventricular ejection fraction (EF). All of them had been stabilized with medical therapy from at least 3 weeks. Plasma NT-pro-BNP, TNF-alpha and CRP levels were measured in each recruited patient. In the whole population we observed a linear correlation between NT-pro-BNP levels, EF and NYHA-class (p<0.05) but there was no significant correlation between TNF-alpha or CRP and the clinical or echocardiographic data (p=0.588 and p=0.9, respectively). Finally we evaluated, if there were significant differences in the biomarker concentrations between diabetics and normoglycemics. Both the clinical and the echocardiographic parameters of systolic dysfunction were comparable in these two groups. We observed a significant difference in CRP levels between the two groups (3.76+/-2.85 in diabetics vs. 1.42+/-2.35 in normoglycemics; p<0.001). The NT-pro-BNP levels were also higher in diabetics than in normoglycemic patients (12867.8+/-18042.0 vs. 6400.89+/-5655.0; p=0.07). Plasma TNF-alpha levels (23.03+/-11.52 vs. 23.31+/-12.0; p=0.93) and left ventricular EF (35.65+/-4.03 vs. 35.18+/-3.55; p=0.63) were similar in the two groups. In agreement with recent studies, we confirm a linear correlation between NT-pro-BNP, EF and the severity of disease in CHF patients. We also observed a greater cytokine activation in diabetics than in normoglycemic patients, demonstrating probably that in this group a greater inflammatory reaction is present.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.archger.2009.02.008 | DOI Listing |
Sci Rep
December 2024
Department of Medical and Surgical Sciences, Institute of Cardiology, University of Bologna, Policlinico S.Orsola-Malpighi, via Massarenti 9, Bologna, 40138, Italy.
Cardiac implantable electronic devices infections (CIEDI) are associated with poor survival despite the improvement in transvenous lead extraction (TLE). Aetiology and systemic involvement are driving factors of clinical outcomes. The aim of this study was to explore their contribute on overall mortality.
View Article and Find Full Text PDFBAY 2413555 is a novel selective and reversible positive allosteric modulator of the type 2 muscarinic acetylcholine (M2) receptor, aimed at enhancing parasympathetic signaling and restoring cardiac autonomic balance for the treatment of heart failure (HF). This study tested the safety, tolerability and pharmacokinetics of this novel therapeutic option. REMOTE-HF was a multicenter, double-blind, randomized, placebo-controlled, phase Ib dose-titration study with two active arms.
View Article and Find Full Text PDFNat Commun
December 2024
Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
The mechanism(s) underlying gut microbial metabolite (GMM) contribution towards alcohol-mediated cardiovascular disease (CVD) is unknown. Herein we observe elevation in circulating phenylacetylglutamine (PAGln), a known CVD-associated GMM, in individuals living with alcohol use disorder. In a male murine binge-on-chronic alcohol model, we confirm gut microbial reorganization, elevation in PAGln levels, and the presence of cardiovascular pathophysiology.
View Article and Find Full Text PDFHealth Expect
February 2025
Osteopathy Sciences Research Unit (URSO), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Objective: Chronic musculoskeletal pain (CMSP) is frequent in chronic diseases, decreasing the quality of life of these patients. In a survey conducted in Belgium in 2019, chronic pain was named by patients as the main factor of complexity in their lives. The objective of our research was to provide elements to understand why and how CMSP contributes to the complexity of these people's lives.
View Article and Find Full Text PDFBrain Commun
December 2024
San Diego Biomedical Research Institute, San Diego, CA 92121, USA.
Hypoxia triggers blood-brain barrier disruption and a strong microglial activation response around leaky cerebral blood vessels. These events are greatly amplified in aged mice which is translationally relevant because aged patients are far more likely to suffer hypoxic events from heart or lung disease, and because of the pathogenic role of blood-brain barrier breakdown in vascular dementia. Importantly, it is currently unclear if disrupted cerebral blood vessels spontaneously repair and if they do, whether surrounding microglia deactivates.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!